Abstract:Background Gliomas are recalcitrant brain tumors. Anti-glioma immunity and immunopathogenic responses are critical contributors for better survival of isocitrate dehydrogenase-mutant (IDHmut) over wild-type (IDHwt) gliomas. Despite this correlative pattern of immunity and survival, an unbiased understanding of cell-type specific transcriptomic and epigenomic states of glioma-derived myeloid cells beyond immunosuppressive paradigms remains elusive. Methods To this end, we performed single-cell RNA-sequencing (scRNA-seq) on 140,000 tumor-associated immune cells from eighteen IDH mutation classified primary (N=8) and recurrent (N=10) human gliomas and three non-glioma brains (NGBs). We performed unsupervised clustering and cell annotation based on overlapping canonical lineage and signal dependent transcription factors. Gene ontology and gene set enrichment analyses were performed to define functional states of glioma associated myeloid cells. Results Our analyses revealed twelve myeloid cell types across glioma subgroups. We noted abundant microglial cells in IDHmut than IDHwt gliomas. Concomitantly, continnum of microglia and macrophage phenotypes were observed in IDHwt glioma, which exhibit more severe tumor pathologies. Strikingly, we identified a hybrid microglia/macrophage cell subset with enriched interferon module inferred from our gene ontology analyses. These hybrid phagocytes were significantly increased in recurrent IDHwt gliomas. As tissue macrophages exhibit multifaceted polarization in response to microenvironmental cues, we clarify the existence of microglia/macrophage functional states beyond M1/M2 paradigms exemplified by the presence of palmitic-, oleic- acid, and glucocorticoid responsive polarized states. Specifically, certain microglia and monocyte-derived subpopulations were associated with antigen presentation gene modules, akin to cross-presenting dendritic cells. Furthermore, immune related gene ontology analysis identified enriched antigen presentation and phagocytosis gene modules in distinct microglia-like clusters. Importantly, the phagocytic immunomodulator; Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) was upregulated in these microglia-like cells. Contrary to tumor promoting role of TREM2 myeloid cells in non-brain cancers, we identify TREM2 axis as a regulator of antigen presentation. Additionally, single cell- Assay for Transposase-Accessible Chromatin using sequencing (sc-ATAC-seq) on ~40,000 tumor-associated microglia revealed genes associated with IFN-gamma/IL-12/IL-10 pathway were negatively regulated in IDHmut/IDHwt microglia compared to homeostatic microglia in NGBs. Conclusions In summary, our study sculpts transcriptional and epigenomic details and re-defines glioma-specific immune contexture for downstream immunogenomics applications. We specifically reveal interferon and TREM2 nodes on microglia-like phagocytic cells as clinically tractable anti-glioma immunotherapy target.

Interferon-β exposure induces a fragile glioblastoma stem cell phenotype with a transcriptional profile of reduced migratory and MAPK pathway activity

Interferon-beta inhibits human glioma stem cell growth by modulating immune response and cell cycle related signaling pathways

Glioma Stem-Like Cells Evade Interferon Suppression Through MBD3/NuRD Complex-Mediated STAT1 Downregulation

Immu-72. Type I Interferon Signaling Within Glioblastoma Cells Promotes T-Cell Exhaustion And Resistance To Checkpoint Inhibitors

Type I interferon signaling regulates myeloid and T cell crosstalk in the glioblastoma tumor microenvironment

Programmed death ligand 1 gene silencing in murine glioma models reveals cell line-specific modulation of tumor growth in vivo

Identification of Molecular Pathways Facilitating Glioma Cell Invasion in Situ.

The Crosstalk between the EGFR and IFN-γ Pathways and Synergistic Roles in Survival Prediction and Immune Escape in Gliomas

Construction of Interferon-Gamma-Related Gene Signature to Characterize the Immune-Inflamed Phenotype of Glioblastoma and Predict Prognosis, Efficacy of Immunotherapy and Radiotherapy

Tumoral Interferon Beta Induces an Immune-Stimulatory Phenotype in Tumor-Associated Macrophages in Melanoma Brain Metastases

Tmic-82. Characterization Of Genetic Markers And Biological Processes Underlying The Transition Of Glioblastoma Cells From A Differentiated To A Stem-Cell-Like State

Radioresistance of mesenchymal glioblastoma initiating cells correlates with patient outcome and is associated with activation of inflammatory program

ISL1 Promotes Human Glioblastoma-Derived Stem Cells' Self-Renewal by Activation of Sonic Hedgehog/GLI1 Function.

Reprogramming Transcription Factors Oct4 and Sox2 Induce a BRD-Dependent Immunosuppressive Transcriptome in GBM-Propagating Cells.

Comparative proteomics as a tool for identifying specific alterations within interferon response pathways in human glioblastoma multiforme cells

Abstract B009: GBM cells mimic regulatory T cell function to protect the CSC pool from immune surveillance in recurrent GBM

Profiling of patients with glioma reveals the dominant immunosuppressive axis is refractory to immune function restoration

Aberrant Expression of Interleukin-1β and Inflammasome Activation in Human Malignant Gliomas

Tumor Cell IDO Enhances Immune Suppression and Decreases Survival Independent of Tryptophan Metabolism in Glioblastoma

1001 Immunophenotyping of Brain Tumors Identifies Interferon Enriched Phagocytes in Human Gliomas

Molecular profiles and immunomodulatory activities of glioblastoma-derived exosomes